PFE · News · 20260820N
Depo-Provera Litigation Settlement
PFIZER INC · 2026-08-20 · Importance 47 · Surprise 60 · In source text
Pfizer established a settlement program covering approximately 5,000 federal lawsuits alleging that Depo-Provera is associated with intracranial meningioma. The program could address most of the more than 6,200 pending federal claims. The agreement is confidential, so its effect on Pfizer’s litigation reserves, legal costs, and public disclosures has not been quantified.
Key facts
- Pfizer has established a settlement program aimed at resolving a significant portion of federal lawsuits concerning Depo-Provera intracranial meningioma, potentially covering around 5,000 of over 6,200 pending claims. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | negative | probable | — | Pfizer has established a settlement program aimed at resolving a significant portion of federal lawsuits concerning Depo-Provera… |